Combination therapy of ranibizumab and photodynamic therapy for retinal angiomatous proliferation with serous pigment epithelial detachment in Korean patients: Twelve-month results

Retina

Volumn 31, Issue 1, 2011, Pages 65-73

  Lee, Mee Yon ^a   Kim, Kyu Seop ^a   Lee, Won Ki ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

age related macular degeneration; photodynamic therapy; pigment epithelial detachment; ranibizumab; retinal angiomatous proliferation

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB; VERTEPORFIN;

AGED; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; PHOTODYNAMIC THERAPY; PIGMENT EPITHELIUM; RETINA ANGIOMATOUS PROLIFERATION; RETINA DETACHMENT; RETINA DISEASE; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ASIAN CONTINENTAL ANCESTRY GROUP; DRUG THERAPY, COMBINATION; EYEGLASSES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PHOTOCHEMOTHERAPY; PILOT PROJECTS; PROSPECTIVE STUDIES; RETINAL DETACHMENT; RETINAL NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 78651371322     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181e586e3     Document Type: Article

References (38)

1. Yannuzzi LA, Negrao S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21:416-434.
2. Yannuzzi LA, Freund KB, Takahashi BS. Review of retinal angiomatous proliferation or type 3 neovascularization. Retina 2008;28:375-384.
3. Freund KB, Ho IV, Barbazetto IA, et al. Type 3 neovascularization: The expanded spectrum of retinal angiomatous proliferation. Retina 2008;28:201-211.
4. Maruko I, Iida T, Saito M, Nagayama D, Saito K. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007;144:15-22.
5. Lee WK, Park YH, Lee PY. Neovascularization associated with large retinal pigment epithelial detachment in elderly Korean patients: Subdivision according to indocyanine green angiographic features. Jpn J Ophthalmol 2007;51:216-223.
6. Kuhn D, Meunier I, Soubrane G, Coscas G. Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelial detachments. Arch Ophthalmol 1995;113:1392-1398.
7. Slakter JS, Yannuzzi LA, Schneider U, et al. Retinal choroidal anastomoses and occult choroidal neovascularization in agerelated macular degeneration. Ophthalmology 2000;107:742-754.
8. Gass JD, Agarwal A, Lavina AM, Tawansy KA. Focal inner retinal hemorrhages in patients with drusen: An early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003;23:741-751.
9. BottoniF,Massacesi A, CigadaM,ViolaF,Musicco I, Staurenghi G. Treatment of retinal angiomatous proliferation in age-related macular degeneration: A series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005;123:1644-1650.
10. Johnson TM, Glaser BM. Focal laser ablation of retinal angiomatous proliferation. Retina 2006;26:765-772.
11. Krieglstein TR, Kampik A, Ulbig M. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation. Br J Ophthalmol 2006;90:1357-1360.
12. Kusserow Michels S, Schmidt-Erfurth U. Chorioretinal anastomosis as unfavourable prognostic factor during photodynamic therapy. Ophthalmologe 2003;23:417-420.
13. Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 2004; 138:1077-1079.
14. Panagiotidis D, Karagiannis DA, Baltatzis S. Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 2006;16:326-329.
15. Boscia F, Parodi MB, Furino C, Reibaldi M, Sborgia C. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2006;244: 1224-1232.
16. Kuroiwa S, Arai J, Gaun S, Iida T, Yoshimura N. Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina 2003;23:417-420.
17. Borrillo JL, Sivalingam A, Martidis A, Federman JL. Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 2003;121:558-561.
18. Shiragami C, Iida T, Nagayama D, Baba T, Shiraga F. Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 2007;27:198-203.
19. Nicolo M, Ghiglione D, Lai S, Calabria G. Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2006;244:1336-1338.
20. Bottoni F, Romano M, Massacesi A, Bergamini F. Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefes Arch Clin Exp Ophthalmol 2006; 244:1528-1533.
21. Boscia F, Furino C, Prascina F, Delle Noci N, Sborgia L, Sborgia C. Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation. Eur J Ophthalmol 2005;15:513-516.
22. Nakata M, Yuzawa M, Kawamura A, Shimada H. Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 2006;141:968-970.
23. Freund KB, Klais CM, Eandi CM, et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiographyguided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006;124:487-492.
24. Meyerle CB, Freund KB, Iturralde D, et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007;27:451-457.
25. Costagliola C, RomanoMR, dell'Omo R, Cipollone U, Polisena P. Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 2007;144:449-451.
26. Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007;245:1597-1602.
27. Lai TY, Chan WM, Liu DT, Lam DS. Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007;245: 1877-1880.
28. Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, Conway BP. Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation. Retina 2008;28:689-695.
29. Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Scab M, Noureddin BN. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study. Am J Ophthalmol 2008;145:249-256.
30. Konstantinidis L, Mameletzi E, Mantel I, Pournaras JA, Zografos L, Ambresin A. Intravitreal ranibizumab (Lucentis) in the treatment of retinal angiomatous proliferation (RAP). Graefes Arch Clin Exp Ophthalmol. 2009;247:1165-1171.
31. Lazic R, Gabric N. Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration. Ophthalmology 2007;114:1179-1185.
32. Heier JS, Boyer DS, Ciulla TA, et al; FOCUS Study Group. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: Year 1 results of the FOCUS study. Arch Ophthalmol 2006;124: 1532-1542.
33. Kaiser PK; Registry of Visudyne AMD Therapy Writing Committee. Verteporfin photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmology 2009;116:747-755.
34. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials-TAP report. Arch Ophthalmol 1999; 117:1329-1345.
35. Saito M, Shiragami C, Shiraga F, Nagayama D, Iida T. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 2008;146:935-941.
36. Lo Giudice G, Gismondi M, De Belvis V, Cian R, Tavolato M, Galan A. Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation. Retina 2009;29:949-955.
37. Rouvas AA, Papakostas TD, Vavvas D, et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: A prospective study. Retina 2009;29:536-544.
38. Rouvas AA, Papakostas TD, Ladas ID, Vergados I. Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2008;246:315-318.